Regulus Therapeutics (RGLS) PT Raised to $1.37 at BMO Capital, Sees Shares 'Range-Bound' Mar 8, 2018 05:52AM
Regulus Therapeutics (RGLS) PT Lowered to $2 at BMO Capital; Probability of RG-101 Success Down to 25% Jan 30, 2017 05:58AM
Regulus Reports Third Quarter 2016 Financial Results Nov 1, 2016 04:10PM
BMO Capital Downgrades Regulus Therapeutics (RGLS) to Market Perform Jun 28, 2016 06:39AM
BMO Capital Starts Regulus Therapeutics (RGLS) at Outperform Apr 11, 2016 04:19PM


Mar 18, 2015 07:56AM Regulus Therapeutics (RGLS) Bullish Stance Reiterated at BMO Capital Following EASL Abstract for RG-101
Feb 9, 2015 10:48AM BMO Capital Reiterates Bullish Stance on Regulus Therapeutics (RGLS) as Incremental Efficacy of RG101 Could Support New Option in HCV
Jan 8, 2015 03:19PM Regulus Therapeutics (RGLS) Gains on Clinical Map Update; BMO Capital Sees Multiple Opportunities to Realize Value
Nov 4, 2014 02:24PM Regulus Therapeutics (RGLS) Price Target Raised to $34 at BMO; Could Attract Interest from Big Pharma, Says Analyst
Oct 29, 2014 06:50AM Regulus Therapeutics (RGLS) 5.29M Offering Prices at $17/Share
Oct 27, 2014 04:01PM Regulus Therapeutics (RGLS) Reports $80M Common Stock Offering
Oct 27, 2014 04:00PM Regulus Therapeutics (RGLS) Announces $80M Common Stock Offering
Oct 22, 2014 12:08PM Streetinsider.com's Hot Lunchtime Reads 10/22: (JNJ) (BIIB) (OCN) (FL) (RGLS)
Oct 22, 2014 11:11AM Regulus (RGLS) Impressive RG101 Results Could Transform HCV Treatment, BMO Capital Says
Jul 17, 2013 08:01AM Regulus Therapeutics (RGLS) Prices 4.5M Shares at $9.50
Oct 31, 2012 08:28AM BMO Capital Starts Regulus Therapeutics (RGLS) at Outperform
Oct 4, 2012 04:09PM Regulus Therapeutics (RGLS) IPO Closes 5% Higher